Pralidoxime Therapy

Pralidoxime Therapy is a specialized form of antidote therapy that functions as a cholinesterase reactivator specifically employed in the treatment of organophosphate poisoning to restore enzymatic activity inhibited by phosphorylation.

289

Publications

10K

Citations

993

Authors

342

Institutions

Publications per year

2017–2026

32

Authors

993

  1. KK
    Kamil Kuča

    University of Hradec Králové, Czechia

    34 publications · 1.2K citations

    22

    h-index

  2. GP
    Georg Petroianu

    United Arab Emirates University, United Arab Emirates

    18 publications · 534 citations

    15

    h-index

  3. SM
    Syed M. Nurulain

    United Arab Emirates University, United Arab Emirates

    14 publications · 387 citations

    12

    h-index

  4. DJ
    Daniel Jun

    University of Defence, Czechia

    12 publications · 300 citations

    10

    h-index

  5. MY
    M. Y. Hasan

    United Arab Emirates University, United Arab Emirates

    9 publications · 241 citations

    9

    h-index

1–5 of 993

Venues

  1. PubMed

    Repository · 31 publications · 1.1K citations

    17

    h-index

  2. Human & Experimental Toxicology

    18 publications · 745 citations

    15

    h-index

  3. Journal of Applied Toxicology

    13 publications · 410 citations

    11

    h-index

  4. Archives of Toxicology

    7 publications · 391 citations

    7

    h-index

  5. Toxicological Sciences

    7 publications · 329 citations

    7

    h-index

1–5